Provexis commits to CV and immunity research
Biotech start-up Provexis says it will commence two clinical trials in 2011 – one in the area of cardiovascular inflammation, the other in treatment of “hospital superbug” c.difficile.
Archives for September 8, 2010
FDA should copy EFSA for health claims, says Scientific American
The FDA is too lenient regarding health claims and should follow EFSA’s lead and hold foods “to the same scientific standards as those for drugs”, according to the editors of Scientific American.
FDA: Lipton green tea is a drug
The Food and Drug Administration has told Unilever Americas that claims for a Lipton green tea product – mostly references to flavonoid studies on Lipton websites – amount to drug claims and must be amended or removed.
ZMC’s completes ‘environmentally responsible’ vit E plant
Zhejiang Medicine Company (ZMC) has announced the completion of an upgrade to its plant for the production of synthetic vitamin E to address environmentally responsible manufacturing.
Omega-3, vitamins C and E may boost pancreatic health
Increased intakes of omega-3 fatty acids, and vitamins C and E may reduce the risk of pancreatic cancer by over 30 percent, suggests new research.
Euromonitor examines functional foods in continental Europe
Tighter spending, more stringent regulations and growing health concerns are all major factors impacting the European market for healthy foods. In the first article of a two-part series, NutraIngredients.com looks at the markets in France, Belgium,...
Vitamin B may help prevent Alzheimer’s
Supplementation with B vitamins may reduce brain wastage and may slow the development of Alzheimer’s, according to a new study.
UK OK’s valerian sleep aids
Relaxation botanical, valerian, has won UK registrations under the European Union 2004 Traditional Herbal Medicinal Products Directive (THMPD), as the registration window moves closer to slamming shut.